BioCentury
ARTICLE | Company News

Glide Pharma, Pfenex deal

April 13, 2015 7:00 AM UTC

NIH’s National Institute of Allergy and Infectious Disease (NIAID) exercised its option to extend a 2012 contract with Pfenex to develop a dry formulation of Px563L-mrPA anthrax vaccine for needle-fr...